XULTOPHY 100/3.6 (insulin degludec and liraglutide injection), for subcutaneous use [prescribing information]
The new offering combines personalized microdoses of GLP-1 medication, regular at-home biomarker testing, and Nooms digital healthy habits platform to empower people with data, insights, personalized action plans and the motivational support to take control of their long-term wellbeing
3 Although well established as an extremely effective medication for glycemic control in diabetes, GLP-1RAs have sparked controversy due to their effect on diabetic retinopathy (DR)
Non-GLP-1 evidence-based weight and metabolic treatments There are other ways to help with weight loss and weight management besides using GLP-1 medicines
DOI.org (Crossref) , Merchant, Warda, et al
It is explicit that berberine is not a substitute for medication in symptomatic type 2 diabetes, particularly above a baseline HbA1c of 7.5 percent